SC 13G Filing

Company

Arbutus Biopharma Corp

Filed

September 11, 2023

Accession Number

0001013594-23-000729

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →